STXS + $.50 to $2.14, just starting
STXS develops, manufactures, and sells medical robotics, a huge growth Industry. STXS has a large, recurring revenue base.
2.5 MM float, 5.5 Million shares OS.
$10 Million market cap.
CEO projects positive EBITDA by 2013.
Just raised $18 million in debt convertible at $3.2 per share.
STXS historically traded at over a $100 million market cap.
STXS trades at a HUGE discount to others in the sector:
HNSN
$22 MM revenue
$109 Million market cap
STXS
$41 million revenue
$10 million market cap.
In short, STXS is a rare find: A company in a huge growth sector turning profitable trading at a huge discount to peers and historical valuations.
